News

Deal to bolster France-based Sebia's capabilities in autoimmunity, infectious diseases and clinical trials

Will closely examine DNA damage response in hopes of improving cancer treatment options

Companies seek to provide a seamless, comprehensive service offering to pharma and clinical research organizations

Arthrex to receive US rights to distribute and commercialize Celularity’s placental-derived biomaterial products for orthopedics and sports medicine

Acquires Sweden-based Sentor, which specializes in security services

Collaboration with Surescripts will focus on improving patient outcomes, while providing HCPs with in-workflow enrollment

Mission is to expand its collection of mRNA vaccines beyond the Covid-19 pandemic

Merger establishes Perigon Health 360—with aim of introducing "precision digital pharmacy" model

The latest people news happenings over the past month

Roche repeats at No. 1 position; AbbVie vaults five spots

Latest addition to its unit load devices for pharma transport aligns with carrier's sustainability goals, company says

Facility will focus on rAAV clinical, commercial gene therapy products

The new independent company Evio is funded by five nonprofit Blue Cross Blue Shield plans

Join forces on tamper-evident security for luer-lock syringes

Acquisition to expand presence in genomic medicine

Aims to enhance company's mRNA and viral vector capabilities

Horizon Therapeutics to purchase production facility from Irish specialty care company

Latest DIANA Awards highlight innovation in healthcare distribution

Newly licensed US facility to increase availability of company's influenza vaccine

Health insurer Anthem joins BCBS organizations to form CivicaScript

Will be expanding to four additional countries in South America

A 16-year data analysis uncovers huge spikes in the number of pharma technicians, pharmacists, and other roles

Commercial-stage company will work with cell therapy partners to advance late-stage clinical programs

Project SKY features one of Europe’s largest facilities for advanced therapies, says CDMO

Via remote data capture, alliance aids outcomes data collection for patients undergoing treatment

Will help UK consortium advance oral solid dosage medicines production

Site expected to begin operations by January 2022

Study of nearly 2,500 young adults deemed the vaccine 100% effective for the 12-17 year-old age group